Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage.

G-CSF granulocyte concentrates leukapheresis neutrophils prednisone

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 20 12 2021
accepted: 24 01 2022
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 24 3 2022
Statut: epublish

Résumé

Transfusion of granulocyte concentrates (GC) is an alternative therapy for neutropenic patients with life-threatening infections. While neutrophils are the main source of antimicrobial activity, only neutrophil numbers are used to certify GCs. The objective of this study was thus to functionally characterize neutrophils in GCs prepared by leukapheresis from G-CSF-stimulated donors and compare to the less characterized prednisone GCs. GCs prepared from healthy donors stimulated with prednisone and then G-CSF after a 6-month washout period were analyzed prior to and after leukapheresis, and after storage. Leukocyte composition, neutrophil viability, calcium mobilization, chemotaxis, phagocytosis, reactive oxygen species, cytokine production and metabolites were determined. G-CSF GCs contained significantly more neutrophils than prednisone GCs of which 40% were immature. In comparison to non-stimulated healthy donor neutrophils, prednisone GC neutrophils exhibited enhanced phagocytosis and G-CSF GC neutrophils showed decreased chemotaxis but increased IL-8 production. Leukapheresis altered prednisone GC neutrophil responses. Storage had a significant, negative impact on G-CSF GC neutrophils compared to prednisone GC neutrophils. G-CSF and prednisone GC neutrophils thus differ in maturity and function, and G-CSF GC neutrophils are more sensitive to storage. Functional testing of GC neutrophils and better storage conditions would improve the quality of this blood product.

Identifiants

pubmed: 35317326
doi: 10.3389/fmed.2022.839475
pmc: PMC8934424
doi:

Types de publication

Journal Article

Langues

eng

Pagination

839475

Informations de copyright

Copyright © 2022 Murru, Allard, Paré, Vaillancourt, Boyer, Cayer, Vitry, Landry, Labrecque, Robitaille, Branch, Girard and Fernandes.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Transfus Med. 2005 Jun;15(3):223-31
pubmed: 15943707
Blood. 1999 Apr 15;93(8):2730-7
pubmed: 10194453
Biochem J. 2006 Jan 1;393(Pt 1):351-9
pubmed: 16171455
Blood. 2000 Jul 15;96(2):429-36
pubmed: 10887102
Haematologica. 2008 Jul;93(7):1058-67
pubmed: 18508794
Sci Transl Med. 2021 Jul 28;13(604):
pubmed: 34321317
Semin Hematol. 2019 Oct;56(4):241-247
pubmed: 31836030
Transfusion. 2001 Mar;41(3):390-5
pubmed: 11274596
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
Sci Rep. 2015 Nov 27;5:17328
pubmed: 26612583
Immunity. 2010 Nov 24;33(5):657-70
pubmed: 21094463
Crit Care Med. 2012 Jan;40(1):43-9
pubmed: 21926615
Front Immunol. 2018 Nov 14;9:2637
pubmed: 30487797
Ann Intern Med. 1966 Feb;64(2):328-40
pubmed: 5216294
Transfusion. 2005 Dec;45(12):1876-89
pubmed: 16371040
Transfus Med. 2007 Aug;17(4):296-303
pubmed: 17680956
Blood. 1987 Mar;69(3):937-44
pubmed: 3814822
Biochem J. 1995 Sep 15;310 ( Pt 3):751-5
pubmed: 7575406
Immunol Rev. 2007 Oct;219:88-102
pubmed: 17850484
Transfusion. 2017 Mar;57(3):674-684
pubmed: 28032635
Eur J Immunol. 1995 Jan;25(1):1-5
pubmed: 7843218
Blood. 2008 Sep 1;112(5):2046-54
pubmed: 18524991
Clin Transpl. 2013;:187-97
pubmed: 25095508
Immunol Today. 1995 Jan;16(1):21-6
pubmed: 7880385
Vox Sang. 2017 Feb;112(2):173-182
pubmed: 28120426
Vox Sang. 2001 Feb;80(2):106-11
pubmed: 11378965
Blood Rev. 2019 Nov;38:100593
pubmed: 31405535
Biochem Pharmacol. 2020 Oct;180:114125
pubmed: 32598947
Blood Res. 2019 Mar;54(1):52-56
pubmed: 30956964
Blood. 2017 Mar 9;129(10):1343-1356
pubmed: 28053192
Transfusion. 2002 May;42(5):603-11
pubmed: 12084169
Transfusion. 2000 Apr;40(4):414-9
pubmed: 10773052
Immunity. 2018 Feb 20;48(2):364-379.e8
pubmed: 29466759
J Leukoc Biol. 2017 Sep;102(3):805-813
pubmed: 28550118
J Leukoc Biol. 2020 Jul;108(1):377-396
pubmed: 32202340
Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S240-5
pubmed: 15768329
Sci Rep. 2017 Jul 18;7(1):5658
pubmed: 28720788
Transfusion. 2000 Sep;40(9):1104-10
pubmed: 10988314
PLoS One. 2012;7(9):e44606
pubmed: 22984532
Physiol Rev. 2019 Apr 1;99(2):1223-1248
pubmed: 30758246
Am J Hematol. 2003 Feb;72(2):82-93
pubmed: 12555210
Blood. 2002 Aug 1;100(3):854-61
pubmed: 12130495

Auteurs

Andréa Murru (A)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.
Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Marie-Ève Allard (MÈ)

Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Guillaume Paré (G)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.

Myriam Vaillancourt (M)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.

Lucie Boyer (L)

Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Marie-Pierre Cayer (MP)

Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Julien Vitry (J)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.

Patricia Landry (P)

Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Marie-Michèle Labrecque (MM)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.

Nancy Robitaille (N)

Transfusion Medicine, Hema-Québec, Québec, QC, Canada.

Donald R Branch (DR)

Center for Innovation, Canadian Blood Services, Departments of Medicine and Lab Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Mélissa Girard (M)

Medical Affairs and Innovation, Hema-Québec, Québec, QC, Canada.

Maria J Fernandes (MJ)

Infectious and Immune Diseases Division, CHU de Québec Research Center, Laval University, Québec, QC, Canada.
Department of Microbiology-Infectious Diseases and Immunology, CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec, QC, Canada.

Classifications MeSH